ETC inhibitors also target glycolytic CSCs, such as CD44+CD24low cells in breast cancer or SP cells in nasopharyngeal carcinoma (Vazquez-Martin et al., 2010; Shen et al., 2013), highlighting the importance of ETC for coupled ATP production, avoiding electron loss in the form of ROS. Here, CD44 is linked to breast carcinoma.